Should a patient with paroxysmal atrial fibrillation and an NSTEMI receive both oral anticoagulants (e.g., apixaban) and aspirin?
Abstract
In patients with paroxysmal AF and an NSTEMI, evidence suggests oral anticoagulants like apixaban reduce stroke risk better than aspirin, but adding aspirin increases bleeding risks. Decisions should consider the individual's thromboembolic versus bleeding risk.
Fields of Study & Subjects
Atrial Fibrillation Management and Outcomes
Antiplatelet Therapy and Cardiovascular Diseases
Venous Thromboembolism Diagnosis and Management
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 9 January 2026